Table 3. Clinicopatholoical features and the status of mutation in intraductal papillary neoplasms (IPNBs).

No.	Age	Sex	Site	Size (cm)	Dysplasia	Subtype	Invasion	Mucin	MUC2	MUC5AC	GNAS	KRAS
1	74	F	periH	8	Int	G	Micro-I	3	0	3	c.602G>A	c.35G>A
2	77	M	periH	2	Int	G	no	3	0	2	c.602G>A	c.35G>A
3	60	M	periH	3.3	Int	G	no	3	3	3	-	c.35G>A, C
4	59	M	periH	2	Int	G	no	3	0	1	c.602G>A	c.35G>A
5	59	F	periH	7.5	Int	I	Invasive	3	3	3	c.602G>A	-
6	63	M	periH	5	Int	G	Invasive	3	0	3	-	-
7	67	M	periH	5	Int	G	Invasive	3	1	2	c.602G>A	-
8	58	F	periH	2.5	Int	G/I	Invasive	3	3	3	-	-
9	62	M	periH	5	High	G/I	Invasive	3	2	3	-	-
10	38	F	periH	2.5	High	Onc	no	2	2	3	-	-
11	80	M	periH	7	Int	G	no	2	0	3	c.602G>A	-
12	49	M	periH	1.7	Int	PB	no	2	1	3	c.602G>A	-
13	78	F	periH	1.8	Int	G/pb	no	2	1	3	-	c.35G>A
14	72	F	periH	5	Int	G/pb	Invasive	2	2	3	c.601C>A	-
15	65	M	periH	7	High	pb/onc	Invasive	2	0	3	c.602G>A	-
16	68	F	periH	2.2	High	G/pb	Invasive	2	1	1	-	c.35G>A, C
17	74	M	distal	2.8	High	G/pb	Invasive	2	1	0	c.602G>A	-
18	57	M	periH	1	Int	G/pb	no	1	1	1	-	-
19	54	M	periH	7	Int	G	Micro-I	1	0	1	-	-
20	52	F	periH	2	Int	G/pb	Micro-I	1	0	3	-	NA
21	67	F	periH	3.2	Int	G/pb	no	1	0	1	c.601C>A c.602G>A	c.35G>A
22	77	F	periH	7	Int	G/pb	Invasive	1	0	3	-	NA
23	65	M	periH	2.5	Int	G/pb	Invasive	1	0	2	c.602G>A	c.35G>A
24	79	F	distal	2.5	High	pb	Invasive	1	0	2	c.602G>A	NA
25	77	M	distal	4	High	G/pb	Invasive	1	1	2	c.602G>A	NA
26	39	M	periH	6.5	High	pb	Invasive	0	0	0	c.602G>A	c.35G>A
27	76	F	periH	6	Int	G/pb	Invasive	0	0	3	-	c.35G>A
28	35	M	distal	7	High	pb	Invasive	0	0	2	-	-
29	72	M	distal	1.2	High	pb	Invasive	0	0	1	-	c.35G>A
30	64	M	distal	3.5	High	pb	Invasive	0	0	1	-	c.35G>A

M, male; F, female; Peri H, perihilar; Int, intermediate; I, intestinal; G, gastric; PB, pancreatobiliary; Onc, oncocytic; micro-I, microinvasion; NA, not available.